Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine
- 31 August 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (2) , 291-297
- https://doi.org/10.1016/s0002-8703(03)00171-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failureAmerican Heart Journal, 2003
- The Oxidative Stress Hypothesis of Congestive Heart FailureChest, 2001
- Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinanAmerican Heart Journal, 2000
- Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridinesAmerican Heart Journal, 2000
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular DysfunctionCirculation, 1996
- Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.Circulation, 1991
- A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.Circulation, 1990
- Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failureJournal of the American College of Cardiology, 1987
- Verapamil in acute myocardial infarctionEuropean Heart Journal, 1984